Form 10-Q Sarepta Therapeutics, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Sarepta Therapeutics (SRPT) Posts Q2 Loss of 85c/Share
August 7, 2014 6:51 AM EDTSarepta Therapeutics (NASDAQ: SRPT) reported Q2 EPS of ($0.85), which may not compare with the analyst estimate of ($0.76). Revenue for the quarter came in at $2.58 million versus the consensus estimate of $4.3 million.
For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.
... More